drugmanrx
1 week ago
DUH! You get so confused, it is no wonder the only thing you can do to communicate here is cut and paste over and over again the same thing.
A different company was in the ticker making those OLD TWEETS, not the current CEO Jason Tucker and Prodigy the current Ticker holder.
Feel free and call either subsidiary and either set up an appointment or purchase a discount Medical card
https://x.com/CNNA_OTC
CNNA
@CNNA_OTC
Cann American Corp. Traded under symbol $CNNA
A holding company for alternative therapeutics, through subsidiaries, Prodigy Stem Cell and Prodigy Health Plus
Hey did you see Former CNNA CEO Jason Black other company SAPX is now OTCID current, and WILL be releasing their first series of $SAPX press releases right away..
I guess OTC Markets doesn't care about his former association with Mark Miller after all.
ROFLMAO!
Hi_Lo
1 week ago
Most recent CNNA quarterly financial statement from 2022:
https://www.otcmarkets.com/file/company/financial-report/348802/content
What happened to this?:
On December 10, 2021, the Company announced the launch of its signature vape cartridge line, C-Juice, a proprietary Delta 8 THC hemp extract that can be
legally consumed in most US states. It is offered in multiple flavors, and will be initially made available in retail outlets in Oklahoma, Kansas and Texas,
eventually branching out into additional markets including online sales.
There was no revenue in the financials concerning this.
On January 3, 2022, the Company announced the retention of a PCAOB auditor, Michael Gillespie & Associates, PLLC, to prepare for full SEC reporting and
an uplisting of the Company's stock.
That was four years ago and still nothing. It's still not SEC reporting, it's still in Expert Market and "uplisting" was a pipe dream.
The Company has a limited operating history and had a cumulative net loss from inception to August 31, 2022 of $8,638,484. The Company has a working
capital deficit of $3,183,521 as at August 31, 2022.
OUCH!!!
Again, what ever happened to this?:
On June 15, 2022, the Company announced it had entered into a lease agreement to develop a 10,000 square feet hemp farming operation in Glencoe,
Oklahoma, allowing the Company to vertically integrate the expansion of its recently-launched "C-Juice" vape lines. It will be managed by the Company's
director, Brad Hangar.
Again, mentioned once and never again. And again, there was no revenue in the financials concerning this and "C-Juice."
You can thank Motor-Goator for encouraging me to dig deeper into this scam company.
Squirrely_McShitty
1 week ago
Honestly haven't considered it that way. It's a good point. It's possible, yes, and I'll continue waiting until end of July & assess. The rule changes are 90% of why I waited. The eternal "hope".
Given we know nothing regarding their cash on hand & internal discussions (even, really, in the broadest sense), my greatest fear is they just ditch the CNNA shell & buy a new one. It may be CNNA is a learning experience & now not worth the hassle. Selling the ticker to another company, even if done by end of year, could take years to show any value, and indeed may never.
Lime Time has the right idea, since he can buy. CNNA has been a great long-term flipping opportunity.
[A]fter 2 years of Finra denying them for not filing the proper financials.(2016 and 2017) from the former ticker holders. to satisfy Finra, They [sic] may decide its may be time to go the OTCIQ route.
Then in 4 years (they already wasted going on 3 years) they will have the 12 years of financials to satisfy Finra and up list to SEC filing.
drugmanrx
2 weeks ago
8K
On March 1, 2023, the Company completed the acquisition of Prodigy Stem Cell, LLC as a wholly owned subsidiary. Prodigy Stem Cell, LLC is a New Jersey based company focused on sales, marketing, and consulting for regenerative medicines.
8K
tem 2.01 Completion of Acquisition or Disposition of Assets.
On May 10, 2023, the Company completed the acquisition of Red Sand Health, LLC, d/b/a Liberty Health Plus as a wholly owned subsidiary of the Company. Upon finalization the Company's board of directors further approved changing the Red Sand Health, LLC, d/b/a from Liberty Health Plus to Prodigy Health Plus.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 10, 2023, the Company appointed Michael G. Kramer as a Director of the Company.
Tues could be a very interesing day.
To initially qualify for OTC Markets' OTCIQ, companies must provide
financial statements covering the previous two fiscal years.
This includes:
Annual Financial Statements: Balance Sheet, Income Statement, Statement of Cash Flows, and Notes to Financial Statements for the two most recently completed fiscal years.
Any Subsequent Quarterly Reports: Since the most recent Annual Repor
Last Annual Report filed 4/12/22 For the period.02/28/2022
Last quarterly filed 10/15/2022 for period ending 08/31/2022
8k
On February 1, 2023, Jason Tucker was appointed as Director, President, CEO, Secretary and Treasurer of the Company. Mr. Tucker has 18 years of experience in Business Development and Project Management. From December of 2020 to October of 2021 Mr. Tucker was CEO of General Environmental Management, Inc. (GEVI), where Mr. Tucker oversaw its successful audit and return to current reporting with the SEC after a decade of dormancy.
Or it might end up being just a Tuesday.
drugmanrx
2 weeks ago
Unfortunately, they have no control when or if they will get out of EM going the fully SEC reporting route.
"call them and ask them when they're going to get off EM. "
All they can do is provide their auditor the data they have and HOPE the auditor can find the data from the former ticker holders and put together something Finra will accept.
But why are you moving the goal post,
The topic is them building a business why they wait for Finra acceptance of their paperwork by their current auditors, it wasn't about when they will get out of EM.
drugmanrx
Re: Squirrely_McShitty post# 43252
Monday, June 23, 2025 3:28:57 PM
Post# of 43261
I won't argue with that "The chances of CNNA seeing current again are slim. "
But one would think one would have accepted that as a possibility when hoping to turn 0.002 to 25 cents.
Paperwork from former ticker holders is the issue, meanwhile company that currently holds the ticker continues to grow it's business..